INOZYME PHARMA, INC.

Insiders Inozyme Pharma, Inc.

Equities

INZY

US45790W1080

Market Closed - Nasdaq Other stock markets 04:00:00 2024-07-15 pm EDT			5-day change	1st Jan Change
5.46 ^USD	+6.02%		+18.70%	+28.17%

Jul. 02	Inozyme Pharma Says US FDA Granted Fast Track Designation to INZ-701 to Treat ABCC6 Deficiency	MT
Jul. 02	Inozyme Pharma Gets FDA Fast Track Designation for INZ-701 in ABCC6 Deficiency	DJ

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Insider Buy: Inozyme Pharma	23-08-04	MT
Insider Buy: Inozyme Pharma	23-05-15	MT
Insider Buy: Inozyme Pharma	23-03-30	MT
Inozyme Pharma, Inc. Announces Management Changes	23-03-22	CI
Inozyme Pharma, Inc. Announces CEO Changes	23-03-22	CI
Inozyme Pharma, Inc. Announces Resignation of Henric Bjarke as Senior Vice President and Chief Operating Officer of the Company	22-12-08	CI
Inozyme Pharma, Inc. Appoints Kurt Gunter as Chief Medical Officer	22-06-07	CI
Insider Buy: Inozyme Pharma	22-04-21	MT
Inozyme Pharma Appoints Former Ocugen Finance Chief Sanjay Subramanian in Same Role	22-03-08	MT
Inozyme Pharma, Inc. Announces Management Changes	22-03-08	CI
Inozyme Pharma, Inc. Announces Appointment of Gayle Gironda as Senior Vice President of Human Resources	21-07-13	CI
Inozyme Pharma, Inc. Announces the Resignation of Stephen Basso as Senior Vice President, Finance, Effective May 14, 2021	21-04-21	CI
Inozyme Pharma Announces Executive Changes	21-04-01	CI
Inozyme Pharma Announces Executive Changes	21-02-04	CI
Inozyme Pharma Appoints Kevin B. Johnson as Senior Vice President, Regulatory Affairs	20-11-09	CI
Inozyme Pharma, Inc. Announces Executive Changes	20-10-13	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Our Free Content Help you Secure and Increase the Performance of Your Investments

Secure my Investments

fermer